Key Takeaways GLP-1 support supplements target the predictable consequences of drug-driven appetite suppression: lean-mass loss, sub-DRI protein, fiber, and micronutrient intake, and GI side effects
How does PlexusDx personalized testing change my side effect experience
2025 Jan;24(1):65-76
Ozempic: Approved by the FDA on June 4, 2021, for chronic weight management in patients with obesity (body mass index of 30 or more) and overweight (body mass index of 27 or more) with a weight-related condition like cardiovascular disease, high blood pressure, or type 2 diabetes
Their capacity to perform the action and exert the necessary effort within the specified timeframe was used as an index of motivational performance (6, 17, 27)
Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala